Skip to main content
Clinical Trials/NCT02870374
NCT02870374
Unknown
N/A

For a Better Interpretation of Quality of Life Scores of Kidney Transplant Patients: Determination of the Minimum Significant Change RetransQol

Assistance Publique Hopitaux De Marseille1 site in 1 country2,000 target enrollmentJanuary 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Kidneys Transplantation
Sponsor
Assistance Publique Hopitaux De Marseille
Enrollment
2000
Locations
1
Primary Endpoint
Number of change in quality of life in kidneys transplantation patients using ReTransQol
Last Updated
9 years ago

Overview

Brief Summary

The project team developped and validated a French patient-based health-related quality of life instrument in kidney transplant: the QoL Retrans.

The aim of the study is to determine the minimum significant change of the valdiated tool: ReTransQol

Registry
clinicaltrials.gov
Start Date
January 2012
End Date
January 2017
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient with a transplant kidney

Exclusion Criteria

  • Patient not able to answer survey

Outcomes

Primary Outcomes

Number of change in quality of life in kidneys transplantation patients using ReTransQol

Time Frame: 1 year

Study Sites (1)

Loading locations...

Similar Trials